NCT00694538

Brief Summary

The purpose of this study is to determine the advantages of the interferential laser therapy in shoulder pain reduction compared with the conventional low level laser therapy modality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2008

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 10, 2008

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

November 13, 2009

Status Verified

November 1, 2009

Enrollment Period

11 months

First QC Date

May 29, 2008

Last Update Submit

November 12, 2009

Conditions

Keywords

Interferential laser therapy

Outcome Measures

Primary Outcomes (1)

  • Pain will be evaluated by visual analog scale (VAS) at rest and during analytical shoulder movements.

    Five minutes

Secondary Outcomes (1)

  • Shoulder Pain Disability Index (SPADI)

    ten minutes

Study Arms (2)

1

ACTIVE COMPARATOR

100 patients are being treated with a single laser beam over pain area.

Device: Interferential Laser therapy

2

EXPERIMENTAL

100 patients are being treated with interferential laser from two independent sources

Device: Interferential Laser therapy

Interventions

Two GaAlAs laser (810 nm, 100mW)were used. In the interferential laser treatment, two probes were simultaneously applied. In the conventional laser group, only one probe was switched on. Laser was applied at five points over the pain area. The laser emission mode was continuous with an energy dose of 6 joules per point and session, a power density of 1.09 w/cm2 and an irradiation time per point of 60 s. The average output power was 100 mW and the total energy dose delivered in a patient session was 30 J. Every treatment was along 15 sessions. Hence, the accumulated energy delivered on the whole was 450 Joules for the conventional group of patients (using one beam) and 900 Joules for the interferential one (using two beams).

Also known as: Interference Laser Therapy., Device Brand Name: Laser Sys. Stim 540(Mettler Electronics)., SN: 105XLS147 (first laser) and 105XLS148 (second laser).
12

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute or chronic pain from musculoskeletal origin
  • Age between 18 and 70 years

You may not qualify if:

  • Brachial plexus palsy
  • Neurological diseases
  • Pacemakers
  • Shoulder pain from cervical pathology
  • Osteosynthesis material
  • Fibromyalgia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Ramon y Cajal

Madrid, Madrid, 28034, Spain

Location

Related Publications (2)

  • Montes-Molina R, Madronero-Agreda MA, Romojaro-Rodriguez AB, Gallego-Mendez V, Prados-Cabiedas C, Marques-Lucas C, Perez-Ferreiro M, Martinez-Ruiz F. Efficacy of interferential low-level laser therapy using two independent sources in the treatment of knee pain. Photomed Laser Surg. 2009 Jun;27(3):467-71. doi: 10.1089/pho.2008.2315.

    PMID: 19405858BACKGROUND
  • Montes-Molina R, Prieto-Baquero A, Martinez-Rodriguez ME, Romojaro-Rodriguez AB, Gallego-Mendez V, Martinez-Ruiz F. Interferential laser therapy in the treatment of shoulder pain and disability from musculoskeletal pathologies: a randomised comparative study. Physiotherapy. 2012 Jun;98(2):143-50. doi: 10.1016/j.physio.2011.02.007. Epub 2011 May 28.

Study Officials

  • Ramon Montes-Molina, PT

    Hospital Ramon y Cajal

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 29, 2008

First Posted

June 10, 2008

Study Start

January 1, 2008

Primary Completion

December 1, 2008

Study Completion

November 1, 2009

Last Updated

November 13, 2009

Record last verified: 2009-11

Locations